Reports Q3 revenue $13.5M, consensus $13.37M. Expect to reach profitability in 2025..”We have achieved significant commercial revenue growth rates for the last three quarters of 40%, 42% and 51%, respectively, over the same periods in the previous year,” said David O’Toole, Chief Financial Officer of AVITA Medical. “Further, we remain confident that our cash reserves position us to achieve our goals and reach profitability in 2025.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RCEL:
- AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
- AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
- Avita Medical announces distribution partnership with PolyMedics
- Avita Medical Ltd (RCEL) Q3 Earnings Cheat Sheet
- AVITA Medical to Announce Third Quarter 2023 Financial Results
